225 related articles for article (PubMed ID: 7693099)
21. Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation.
Park JH; Corkins MR; Vanderhoof JA; Caruso NM; Hrbek MJ; Schaffer BS; Slentz DH; McCusker RH; MacDonald RG
J Cell Physiol; 1996 Feb; 166(2):396-406. PubMed ID: 8592000
[TBL] [Abstract][Full Text] [Related]
22. IGF-I and IGF-binding proteins: stimulatory and inhibitory factors secreted by human prostatic adenocarcinoma cells.
Kaicer EK; Blat C; Harel L
Growth Factors; 1991; 4(3):231-7. PubMed ID: 1722685
[TBL] [Abstract][Full Text] [Related]
23. Secretion of insulin-like growth factor (IGF)-I and -II and IGF binding proteins (IGFBPs) in fetal stromal-vascular (S-V) cell cultures obtained before and after the onset of adipogenesis in vivo.
Hausman GJ; Richardson RL; Simmen FA
Growth Dev Aging; 2002; 66(1):11-26. PubMed ID: 12212627
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Caco-2 cell proliferation by all-trans retinoic acid: role of insulin-like growth factor binding protein-6.
Kim EJ; Kang YH; Schaffer BS; Bach LA; MacDonald RG; Park JH
J Cell Physiol; 2002 Jan; 190(1):92-100. PubMed ID: 11807815
[TBL] [Abstract][Full Text] [Related]
25. Human prostate cancer expresses the low affinity insulin-like growth factor binding protein IGFBP-rP1.
Degeorges A; Wang F; Frierson HF; Seth A; Chung LW; Sikes RA
Cancer Res; 1999 Jun; 59(12):2787-90. PubMed ID: 10383131
[TBL] [Abstract][Full Text] [Related]
26. Rat prostate cancer cell line-specific production and apparent secretion of heparin-binding growth factors.
Shain SA; Ke LD; Wong G; Karaganis AG
Cell Growth Differ; 1992 Apr; 3(4):249-58. PubMed ID: 1381214
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of growth and regulation of IGFs and VEGF in human prostate cancer cell lines by shikonin analogue 93/637 (SA).
Gaddipati JP; Mani H; Shefali ; Raj K; Mathad VT; Bhaduri AP; Maheshwari RK
Anticancer Res; 2000; 20(4):2547-52. PubMed ID: 10953325
[TBL] [Abstract][Full Text] [Related]
28. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.
Miyake H; Pollak M; Gleave ME
Cancer Res; 2000 Jun; 60(11):3058-64. PubMed ID: 10850457
[TBL] [Abstract][Full Text] [Related]
29. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of IGFBP-5 binding to extracellular matrix and IGF-I-stimulated DNA synthesis by a peptide fragment of IGFBP-5.
Rees C; Clemmons DR
J Cell Biochem; 1998 Dec; 71(3):375-81. PubMed ID: 9831074
[TBL] [Abstract][Full Text] [Related]
31. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A
Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450
[TBL] [Abstract][Full Text] [Related]
32. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
[TBL] [Abstract][Full Text] [Related]
33. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3).
Angelloz-Nicoud P; Binoux M
Endocrinology; 1995 Dec; 136(12):5485-92. PubMed ID: 7588299
[TBL] [Abstract][Full Text] [Related]
34. Accumulation of insulin-like growth factor binding protein-3 in conditioned medium of human fibroblasts increases with chronologic age of donor and senescence in vitro.
Goldstein S; Moerman EJ; Baxter RC
J Cell Physiol; 1993 Aug; 156(2):294-302. PubMed ID: 7688372
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
[TBL] [Abstract][Full Text] [Related]
36. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation.
Park JH; McCusker RH; Vanderhoof JA; Mohammadpour H; Harty RF; MacDonald RG
Endocrinology; 1992 Sep; 131(3):1359-68. PubMed ID: 1380441
[TBL] [Abstract][Full Text] [Related]
37. Purification from transformed mouse fibroblast of a cell growth inhibitor which is an IGF-binding protein.
Blat C; Villaudy J; Delbé J; Troalen F; Golde A; Harel L
Growth Factors; 1992; 6(1):65-75. PubMed ID: 1375478
[TBL] [Abstract][Full Text] [Related]
38. Evidence that the inhibition of TE85 human bone cell proliferation by agents which stimulate cAMP production may in part be mediated by changes in the IGF-II regulatory system.
Mohan S; Baylink DJ
Growth Regul; 1991 Sep; 1(3):110-8. PubMed ID: 1726835
[TBL] [Abstract][Full Text] [Related]
39. Regulation of IGFBP secretion and modulation of cell growth in MDBK cells.
Cohick WS; Clemmons DR
Growth Regul; 1993 Mar; 3(1):20-3. PubMed ID: 7683518
[TBL] [Abstract][Full Text] [Related]
40. An inhibitory insulin-like growth factor binding protein (In-IGFBP) from human prostatic cell conditioned medium reveals N-terminal sequence identity with bone derived In-IGFBP.
Perkel VS; Mohan S; Baylink DJ; Linkhart TA
J Clin Endocrinol Metab; 1990 Aug; 71(2):533-5. PubMed ID: 1696279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
